Patent-Eligibility of Stem Cells Under New USPTO “Myriad-Mayo” Guidance
Patent-Eligibility of Stem Cells Under New USPTO “Myriad-Mayo” Guidance In March, the U.S. Patent and Trademark Office (USPTO) implemented new procedures to address whether inventions that relate in whole or in part to laws...
Recent Comments